Compensation Committee Uses in TERM OF AGREEMENT Clause

TERM OF AGREEMENT from Severance Agreement

This Severance Agreement (this "Agreement") dated as of September 25, 2015 (the "Effective Date"), between Zoe's Kitchen, Inc., a Delaware corporation (the "Company"), and Sunil Doshi (the "Employee").

TERM OF AGREEMENT. This Agreement shall commence on Employee's first day of employment with the Company and shall terminate automatically without further notice upon the Company's Board of Directors (or Compensation Committee thereof) adopting a new severance policy or agreement applicable to the CFO, provided, however, that any such terms of the new severance policy or agreement shall have economic terms no less favorable to Employee in any material respect than the economic terms stated herein. Nothing herein shall modify the at-will nature of the Employee's employment relationship with the Company.

Term of Agreement from Executive Employment Agreement

THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement''), dated as of August 10, 2015 (the "Effective Date") is made and entered into by and between the KonaRed Corporation, a Nevada corporation (the "Company"), and Kyle Redfield (the "Executive").

Term of Agreement. This Agreement shall continue in full force and effect until the third anniversary of the Effective Date (the "Initial Term"), and shall automatically renew for additional one (1) year renewal periods (a "Renewal Term") if Executive is employed by the Company on the last day of the Initial Term and on each Renewal Term; provided, however, that within the sixty (60) to ninety (90) day period prior to the expiration of the Initial Term or any Renewal Term, at its discretion, the Compensation Committee may propose for consideration by Executive, such amendments to the Agreement as it deems appropriate. If Executive's employment with the Company terminates during the Initial Term or a Renewal Term, this Agreement shall remain in effect until all of the obligations of the parties hereunder are satisfied or have expired.

Term of Agreement from Severance Benefit Agreement

This SEVERANCE BENEFIT & CHANGE IN CONTROL Agreement (the Agreement) is entered into on April 1, 2014 between American Science and Engineering, Inc. (the Company or the Employer, either of which term shall include any successor by merger, consolidation, sale of substantially all of the Companys assets or otherwise) and (Executive) to be effective on April 1, 2014 (the Effective Date).

Term of Agreement. The Agreement shall become effective on the Effective Date and shall terminate on March 31, 2015, other than as specified in this section and Section 9 hereof; provided that this Agreement shall automatically be extended for successive one year terms unless the Compensation Committee of the Board (organization) values">Compensation Committee of the Board provides Executive with written notice to the contrary at least 30 days before the date the Agreement would otherwise be so extended. Such notice, in the sole discretion of the Compensation Committee, may provide that the term will not be extended in the future, and/or that there shall be no further automatic extensions of the term. Nonextension of the Agreement does not terminate Executives employment nor entitle him or her to any payments under this Agreement, nor are any such payments due on a termination of employment or resignation for Good Reason that occurs after the term of this Agreement. The Compensation Committee may not provide a notice of nonextension during a Pending Change in Control (as defined in Section 4(a).

Term of Agreement from Severance Benefits Agreement

This Change In Control and Severance Benefits Agreement (the "Agreement") is entered into this 2nd day of December, 2013 (the "Effective Date"), between ViewPoint Financial Group, Inc. (the "Company") and [*] ("Executive"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events, and supersedes that certain severance agreement dated [*] between Company and Executive.

Term of Agreement. The term of this Agreement shall be a period of one year beginning on the Effective Date, subject to earlier termination as provided herein. On the first anniversary of the Effective Date, and on each anniversary thereafter, the term of this Agreement shall be extended for a period of year provided that within the 90-day period prior to such anniversary, the Compensation Committee explicitly reviews and approves the extension. Reference herein to the term of this Agreement shall refer to both such initial term and such extended terms.

Term of Agreement from Severance Benefits Agreement

This Change In Control and Severance Benefits Agreement (the "Agreement") is entered into this ___st day of November, 2013, between ViewPoint Financial Group, Inc. (the "Company") and Mays Davenport ("Executive"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

Term of Agreement. The term of this Agreement shall be a period of one year beginning on that date on which the last of the Articles of Merger are filed in the state of incorporation of ViewPoint Financial Group, Inc. or LegacyTexas Group, Inc. (the "Effective Date"), subject to earlier termination as provided herein. On the first anniversary of the Effective Date, and on each anniversary thereafter, the term of this Agreement shall be extended for a period of one year provided that within the 90-day period prior to such anniversary, the Compensation Committee explicitly reviews and approves the extension. Reference herein to the term of this Agreement shall refer to both such initial term and such extended terms.

Term of Agreement from Severance Benefits Agreement

This Change In Control and Severance Benefits Agreement (the "Agreement") is entered into this ___st day of November, 2013, between ViewPoint Financial Group, Inc. (the "Company") and Mays Davenport ("Executive"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

Term of Agreement. The term of this Agreement shall be a period of one year beginning on that date on which the last of the Articles of Merger are filed in the state of incorporation of ViewPoint Financial Group, Inc. or LegacyTexas Group, Inc. (the "Effective Date"), subject to earlier termination as provided herein. On the first anniversary of the Effective Date, and on each anniversary thereafter, the term of this Agreement shall be extended for a period of one year provided that within the 90-day period prior to such anniversary, the Compensation Committee explicitly reviews and approves the extension. Reference herein to the term of this Agreement shall refer to both such initial term and such extended terms.

TERM OF AGREEMENT from Change of Control and Severance Benefits Agreement

This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the "Agreement") is effective the fifteenth day of July 2013 (the "Effective Date"), between TRANSCEPT PHARMACEUTICALS, INC. (the "Company") and John A. Kollins ("Executive"). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of May 31, 2012, as amended (the "Prior Agreement"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and shall continue through May 31, 2017 (the "Expiration Date"), and if not amended or renewed by the Compensation Committee of the Company's Board of Directors (the "Compensation Committee") prior to the Expiration Date, this Agreement shall terminate automatically on such Expiration Date. Notwithstanding the foregoing, the Company agrees that during the one-year period before the Expiration Date, the Compensation Committee shall undertake to review this Agreement and the severance benefits and change of control severance benefits provided herein in good faith, with the assistance of the Company's outside advisors and compensation consultants, in order to determine, based upon the then current market conditions or any other factors deemed relevant by the Compensation Committee, the appropriateness of continuing this Agreement after the Expiration Date, or whether it would be more appropriate for the Company to amend or terminate this Agreement as of the Expiration Date.

TERM OF AGREEMENT from Change of Control and Severance Benefits Agreement

This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the "Agreement") is effective the fifteenth day of July 2013 (the "Effective Date"), between TRANSCEPT PHARMACEUTICALS, INC. (the "Company") and Nikhilesh Singh, Ph.D., ("Executive"). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of April 30, 2009, as amended (the "Prior Agreement"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and shall continue through April 30, 2017 (the "Expiration Date"), and if not amended or renewed by the Compensation Committee of the Company's Board of Directors (the "Compensation Committee") prior to the Expiration Date, this Agreement shall terminate automatically on such Expiration Date. Notwithstanding the foregoing, the Company agrees that during the one-year period before the Expiration Date, the Compensation Committee shall undertake to review this Agreement and the severance benefits and change of control severance benefits provided herein in good faith, with the assistance of the Company's outside advisors and compensation consultants, in order to determine, based upon the then current market conditions or any other factors deemed relevant by the Compensation Committee, the appropriateness of continuing this Agreement after the Expiration Date, or whether it would be more appropriate for the Company to amend or terminate this Agreement as of the Expiration Date.

TERM OF AGREEMENT from Change of Control and Severance Benefits Agreement

This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the "Agreement") is effective the fifteenth day of July 2013 (the "Effective Date"), between TRANSCEPT PHARMACEUTICALS, INC. (the "Company") and Leone Patterson ("Executive"). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of May 22, 2012, as amended (the "Prior Agreement"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and shall continue through May 22, 2017 (the "Expiration Date"), and if not amended or renewed by the Compensation Committee of the Company's Board of Directors (the "Compensation Committee") prior to the Expiration Date, this Agreement shall terminate automatically on such Expiration Date. Notwithstanding the foregoing, the Company agrees that during the one-year period before the Expiration Date, the Compensation Committee shall undertake to review this Agreement and the severance benefits and change of control severance benefits provided herein in good faith, with the assistance of the Company's outside advisors and compensation consultants, in order to determine, based upon the then current market conditions or any other factors deemed relevant by the Compensation Committee, the appropriateness of continuing this Agreement after the Expiration Date, or whether it would be more appropriate for the Company to amend or terminate this Agreement as of the Expiration Date.

TERM OF AGREEMENT from Change of Control and Severance Benefits Agreement

This AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the "Agreement") is effective the fifteenth day of July 2013 (the "Effective Date"), between TRANSCEPT PHARMACEUTICALS, INC. (the "Company") and Glenn A. Oclassen ("Executive"). This Agreement amends and restates in its entirety that certain Change of Control and Severance Benefits Agreement by and between the Executive and the Company dated as of April 30, 2009 as amended (the "Prior Agreement"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.

TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and shall continue through April 30, 2017 (the "Expiration Date"), and if not amended or renewed by the Compensation Committee of the Company's Board of Directors (the "Compensation Committee") prior to the Expiration Date, this Agreement shall terminate automatically on such Expiration Date. Notwithstanding the foregoing, the Company agrees that during the one-year period before the Expiration Date, the Compensation Committee shall undertake to review this Agreement and the severance benefits and change of control severance benefits provided herein in good faith, with the assistance of the Company's outside advisors and compensation consultants, in order to determine, based upon the then current market conditions or any other factors deemed relevant by the Compensation Committee, the appropriateness of continuing this Agreement after the Expiration Date, or whether it would be more appropriate for the Company to amend or terminate this Agreement as of the Expiration Date.